Quick Answer
NeuroPace Inc reported Total Revenue of $99.99 million for the year ending 2025.
- NeuroPace Inc showed an increase of +25.1% in Total Revenue from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $9.98 million | Q2 2020: $7.64 million | Q3 2020: $12.77 million | Q1 2021: $11.22 million | Q2 2021: $12.63 million | Q3 2021: $10.34 million | Q1 2022: $11.37 million | Q2 2022: $10.20 million | Q3 2022: $11.16 million | Q1 2023: $14.47 million | Q2 2023: $16.51 million | Q3 2023: $16.43 million | Q1 2024: $18.12 million | Q2 2024: $19.26 million | Q3 2024: $21.06 million | Q1 2025: $22.52 million | Q2 2025: $23.52 million | Q3 2025: $27.35 million.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Total Revenue has grown by 143.1%.
- Historical annual values: Fiscal year 2025: $99.99 million | Fiscal year 2024: $79.91 million | Fiscal year 2023: $65.42 million | Fiscal year 2022: $45.52 million | Fiscal year 2021: $45.18 million | Fiscal year 2020: $41.14 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: